Illinois medical cannabis rules now include PMOS with chronic pain and sickle cell disease as qualifying conditions. IDPH approved the additions after advisory review, allowing providers to certify eligible patients and bringing the state’s approved-condition list to 58.
Illinois has added polyendocrine metabolic ovarian syndrome, or PMOS, with chronic pain and sickle cell disease to the conditions that can qualify patients for the state’s Medical Cannabis Patient Program.
The Illinois Department of Public Health announced the change on Tuesday, August 25, 2026. IDPH Director Dr. Sameer Vohra approved both conditions following review by the Medical Cannabis Advisory Board and department staff. The orders took effect immediately, allowing health care providers to begin certifying eligible patients.
Illinois medical cannabis list expands to 58 conditions
Under Illinois law, petitions can be submitted seeking the addition of debilitating medical conditions to the medical cannabis program. The IDPH director considers scientific analysis and medical literature when deciding whether a condition should qualify.
The two additions bring Illinois’ list of qualifying debilitating conditions to 58, according to IDPH.
PMOS with chronic pain becomes eligible
Illinois specifically approved PMOS when it is accompanied by chronic pain. IDPH describes polyendocrine metabolic ovarian syndrome as the newer name for polycystic ovary syndrome, or PCOS.
The department says the condition involves hormonal changes affecting areas including metabolism, reproductive health, skin and mental well-being. Eligible residents with PMOS-related chronic pain may now seek provider certification.
Sickle cell disease added to qualifying list
Sickle cell disease refers to a group of inherited red blood cell disorders that can cause severe pain, anemia, fatigue, swelling, infections and organ damage.
IDPH added the disease to the qualifying list after reviewing its use of medical cannabis for pain associated with the condition.
Patients must still meet Illinois requirements
The change does not automatically enroll patients. Applicants must satisfy Illinois Medical Cannabis Patient Program requirements and obtain the required provider certification.
The state’s qualifying list also includes chronic pain, Crohn’s disease, endometriosis, migraines, ovarian cysts, PTSD and severe fibromyalgia. IDPH continues to administer the registry and the process for considering additional debilitating conditions.
